Centre Hospitalier de Colmar
8
5
5
3
Key Highlights
Risk & Performance
Pipeline Risk Assessment
Pipeline Risk Assessment
Based on historical performance
Moderate Risk
Score: 45/100
0.0%
0 terminated/withdrawn out of 8 trials
100.0%
+13.4% vs industry average
0%
0 trials in Phase 3/4
0%
0 of 3 completed trials have results
Key Signals
Enrollment Performance
Analytics
Activity Timeline
Global Presence
Clinical Trials (8)
ALZEVIT: Nationwide Digital APOE ε4 Cohort for Early Alzheimer's Disease Prevention and Trial Readiness
Role: collaborator
Effect of Aromatherapy on the Management of Chemotherapy-Induced Neuropathy (CIN)
Role: lead
Analysis of Factors Associated With Delayed Medical Consultation for Testicular Torsion Among Adolescents in the Haut-Rhin Department Between 2020 and 2025
Role: lead
Prevalence of Neuropathic Pain After Non-instrumented Lumbar Spinal Surgery
Role: lead
Quality of Life After Breast Cancer Surgery
Role: lead
Study of the Adequacy Between Calcium Supplementation and Dietary Intake in Treatment-naive Patients After a Fracture
Role: lead
Out of Hospital Cardiac Arrest: Trial Assessing the Survival Impact of Phone Advice
Role: collaborator
Decision to Limit or Withdraw Specific Therapies for Advanced Cancer and Hematological Malignancies.
Role: collaborator
All 8 trials loaded